Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia

Acute lymphoblastic leukaemia (ALL) is the most common paediatric cancer (25% of all cases). Children with Down syndrome (constitutive trisomy 21) are predisposed to ALL with inferior prognosis compared to other children. I established novel models of DS-ALL to dissect the role of trisomy 21 and ide...

Full description

Bibliographic Details
Main Author: Carey-Smith, Shannon Lee
Format: Thesis
Published: Curtin University 2024
Online Access:http://hdl.handle.net/20.500.11937/95646
_version_ 1848766037391048704
author Carey-Smith, Shannon Lee
author_facet Carey-Smith, Shannon Lee
author_sort Carey-Smith, Shannon Lee
building Curtin Institutional Repository
collection Online Access
description Acute lymphoblastic leukaemia (ALL) is the most common paediatric cancer (25% of all cases). Children with Down syndrome (constitutive trisomy 21) are predisposed to ALL with inferior prognosis compared to other children. I established novel models of DS-ALL to dissect the role of trisomy 21 and identify new potent inhibitors of the chromosome 21 kinase DYRK1A. Altogether, this project provides new preclinical tools to improve the outcomes of children with Down syndrome that develop leukaemia.
first_indexed 2025-11-14T11:44:46Z
format Thesis
id curtin-20.500.11937-95646
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T11:44:46Z
publishDate 2024
publisher Curtin University
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-956462024-08-05T06:29:23Z Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia Carey-Smith, Shannon Lee Acute lymphoblastic leukaemia (ALL) is the most common paediatric cancer (25% of all cases). Children with Down syndrome (constitutive trisomy 21) are predisposed to ALL with inferior prognosis compared to other children. I established novel models of DS-ALL to dissect the role of trisomy 21 and identify new potent inhibitors of the chromosome 21 kinase DYRK1A. Altogether, this project provides new preclinical tools to improve the outcomes of children with Down syndrome that develop leukaemia. 2024 Thesis http://hdl.handle.net/20.500.11937/95646 Curtin University fulltext
spellingShingle Carey-Smith, Shannon Lee
Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
title Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
title_full Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
title_fullStr Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
title_full_unstemmed Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
title_short Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
title_sort towards understanding the role of trisomy 21 in down syndrome leukaemia
url http://hdl.handle.net/20.500.11937/95646